PamBio's Unattributed Round

PamBio raised a round of funding on July 19, 2016.

PamBio operates as a biotechnology company that develops drug therapy for acute bleeding conditions. The company's main product is an anti-fibrinolytic agent that is an inactive, mutated Tissue Plasmi…

Articles about PamBio's Unattributed Round: